Description |
matrix metallopeptidase 3 |
plasminogen |
Image |
|
|
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
- Marimastat
- N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide
- 3-Methylpyridine
- A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor
- N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide
- (1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine
- 3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid
- Hydroxyaminovaline
- 4-methoxybenzenesulfinate
- 5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione
- 1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide
- N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide
- R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid
- 2-[3-(5-Mercapto-[1,3,4]thiadiazol-2-yl)-ureido]-N-methyl-3-phenyl-propionamide
- [4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID
- [2-(5-Mercapto-[1,3,4]thiadiazol-2-ylcarbamoyl)-1-phenyl-ethyl]-carbamic acid benzyl ester
- 2-[3-(5-Mercapto-[1,3,4]thiadiazol-2yl)-ureido]-N-methyl-3-pentafluorophenyl-propionamide
- N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide
- 3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide
- N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID
- N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID
- 2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER
|
|
Diseases |
|
|
GWAS |
- Alzheimer's disease ( 22832961)
- Blood protein levels ( 30072576 28240269)
- Blood protein levels in cardiovascular risk ( 28369058)
- Cerebrospinal fluid levels of Alzheimer's disease-related proteins ( 25340798)
- Peripheral artery disease ( 31285632)
- Post bronchodilator FEV1/FVC ratio ( 26634245)
- Post bronchodilator FEV1/FVC ratio in COPD ( 26634245)
|
- Aging ( 22773346)
- Blood protein levels ( 29875488 28240269)
- Body mass index ( 26426971)
- Body mass index (age>50) ( 26426971)
- Body mass index x sex x age interaction (4df test) ( 26426971)
- Childhood ear infection ( 27182965 28928442)
- Cognitive decline rate in late mild cognitive impairment ( 26252872)
- Coronary artery disease ( 26343387 33020668)
- Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease) ( 28714975)
- End stage renal disease x APOL1 genotype interaction ( 29885931)
- Giant cell arteritis ( 28041642)
- HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- LDL cholesterol levels in current drinkers ( 30698716)
- LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Lipoprotein (a) levels ( 26377243)
- Lipoprotein (a) levels in response to niacin in statin-treated individuals ( 30371334)
- Lp (a) levels ( 21900290)
- Myocardial infarction ( 26343387)
- Plasma plasminogen levels ( 25208887)
- Platelet count ( 32888494)
- Triglyceride levels ( 32203549)
- Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
|
Interacting Genes |
19 interacting genes:
ACAN
BCAN
CCL13
CCL2
CCL7
CCL8
DCN
HAPLN1
IGFBP3
MEOX2
MMP14
PLG
SERPINE1
SPOCK1
SPOCK3
SPP1
TIMP1
TIMP3
TNFSF11
|
60 interacting genes:
ACTB
AMOT
ANXA2
APOH
ATP5F1B
C7
CDCP1
CHGA
CLEC3B
CP
CPB2
CXCL2
CYFIP2
ENO1
EP300
F10
F2R
F2RL1
F3
FN1
HMGB1
HRG
HSPA1A
HSPB1
HSPD1
IGF2
IGFBP3
KLK3
KNG1
LAMA1
LAMA3
MAPK14
MEP1A
MMP3
MMP7
MMP9
NGF
PAPPA
PCOLCE
PLAT
PLAU
PRDX4
PRNP
RAP2A
RBBP6
RUVBL1
S100A10
SERPINB13
SERPINB6
SERPINC1
SERPINE1
SERPINF2
SERPING1
SERPINI1
SMAD3
SMAD4
SPARC
TFPI2
THBS1
YTHDC1
|
Entrez ID |
4314 |
5340 |
HPRD ID |
01703 |
01417 |
Ensembl ID |
ENSG00000149968
|
ENSG00000122194
|
Uniprot IDs |
P08254
|
P00747
Q5TEH5
|
PDB IDs |
1B3D
1B8Y
1BIW
1BM6
1BQO
1C3I
1C8T
1CAQ
1CIZ
1CQR
1D5J
1D7X
1D8F
1D8M
1G05
1G49
1G4K
1HFS
1HY7
1M1W
1OO9
1QIA
1QIC
1SLM
1SLN
1UEA
1UMS
1UMT
1USN
2D1O
2JNP
2JT5
2JT6
2SRT
2USN
3OHL
3OHO
3USN
4DPE
4G9L
4JA1
6MAV
6N9D
|
1B2I
1BML
1BUI
1CEA
1CEB
1DDJ
1HPJ
1HPK
1I5K
1KI0
1KRN
1L4D
1L4Z
1PK4
1PKR
1PMK
1QRZ
1RJX
2DOH
2DOI
2KNF
2L0S
2PK4
3UIR
4A5T
4CIK
4DCB
4DUR
4DUU
5HPG
5UGD
5UGG
6D3X
6D3Y
6D3Z
6D40
6OG4
6OQJ
6OQK
6Q1U
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|